Johnson Johnson Urges FDA To Take Interim Steps As It Continues To Review CBD
The FDA''s Science Board has once again reviewed the idea of incorporating cannabinoids into dietary supplements. At a Tuesday meeting with the FDA''s public advisory committee, the panel focused on “challenges in evaluating the safety of dietary supplement and food ingredients with predicted pharmacological activity, utilizing cannabinoids as a case study.” Drugmaker Johnson Johnson (NYSE: JNJ ) was one of many businesses that urged health regulators to come up with rules on incorporating CBD in food and dietary supplements , reported Cannabis Wire. One of the executives at the company’s pharmaceutical arm, Cynthia Afshari, said the regulatory body could “start to chip away” at the issue of CBD, which … Full story available on Benzinga.com
Johnson Johnson Urges FDA To Take Interim Steps As It Continues To Review CBD
The FDA''s Science Board has once again reviewed the idea of incorporating cannabinoids into dietary supplements. At a Tuesday meeting with the FDA''s public advisory committee, the panel focused on “challenges in evaluating the safety of dietary supplement and food ingredients with predicted pharmacological activity, utilizing cannabinoids as a case study.” Drugmaker Johnson Johnson (NYSE: JNJ ) was one of many businesses that urged health regulators to come up with rules on incorporating CBD in food and dietary supplements , reported Cannabis Wire. One of the executives at the company’s pharmaceutical arm, Cynthia Afshari, said the regulatory body could “start to chip away” at the issue of CBD, which … Full story available on Benzinga.com